What is Prednisolone?
Category: Prescription Drugs
Most popular types: Panafcortelone Wysolone Predalone 50 Show all
See also: IGEV regimen
Prednisolone is a corticosteroid with anti-inflammatory as well as immune-suppressing properties. It can be used to treat a wide-range of inflammatory conditions.
| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Ulcerative colitis | 429 | 27 | |
| Autoimmune hepatitis | 42 | 14 | |
| Rheumatoid arthritis | 35 | 16 | |
| Eosinophilic gastroenteritis | 14 | 0 | |
| Idiopathic pulmonary fibrosis | 14 | 7 |
- Major
- Moderate
- Slight
- None
- Can't tell
Side effects
Side effects as an overall problem
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 19 | |
| Moderate | 58 | |
| Mild | 36 | |
| None | 40 |
Commonly reported side effects and conditions associated with Prednisolone
| Side effect | Patients | Percentage |
|---|---|---|
| Weight gain | 31 | |
| Moon face | 12 | |
| Insomnia | 11 | |
| Mood swings | 9 | |
| Anxious mood | 7 | |
| Increased appetite | 7 |
Why patients stopped taking Prednisolone
Multiple reasons could be selected
| Reason | Patients | Percentage |
|---|---|---|
| Course of treatment ended | 79 | |
| Doctor's advice | 33 | |
| Side effects too severe | 17 | |
| Did not seem to work | 11 | |
| Other | 10 | |
| Personal research | 2 | |
| Change in health plan coverage | 1 |
Duration
Stopped taking Prednisolone
| Duration | Patients | Percentage |
|---|---|---|
| Less than 1 month | 41 | |
| 1 - 6 months | 28 | |
| 6 months - 1 year | 13 | |
| 1 - 2 years | 10 | |
| 2 - 5 years | 11 | |
| 5 - 10 years | 5 | |
| 10 years or more | 4 |
What people switch to and from
Patients started taking Prednisolone after stopping:
| Treatment | Patients | Percentage |
|---|---|---|
| Buprenorphine patch (BuTrans patch) | 1 | |
| Dexamethasone (Decadron) | 1 | |
| Methotrexate (Apo-Methotrexate) | 1 | |
| Pomalidomide-dexamethasone | 1 | |
| Salmeterol (Serevent) | 1 |
Patients stopped taking Prednisolone and switched to:
| Treatment | Patients | Percentage |
|---|---|---|
| Budesonide (Pulmicort) | 3 | |
| Azathioprine (Imuran) | 2 | |
| Infliximab (Remicade) | 2 | |
| Methylprednisolone (Solu-Medrol Infusion) | 2 | |
| Abatacept (Orencia) | 1 |
Last updated: